Investigating the clinical manifestations, severity and outcomes of COVID-19 among inpatients with rheumatic diseases: A retrospective cross-sectional study in Iran

Introduction — Patients with rheumatic diseases (RD) may be at an increased risk of developing severe symptoms of COVID-19. They are likely to have a wide range of manifestations and outcomes that can make it difficult to control the disease. The goal of this study was to investigate the clinical ma...

Full description

Saved in:
Bibliographic Details
Main Authors: Alireza Sadeghi, Fazlollah Ayatollahi, Sana Gheytarani, Somayeh Abdollahi Sabet, Mina Rostami
Format: Article
Language:English
Published: Limited liability company «Science and Innovations» (Saratov) 2024-09-01
Series:Russian Open Medical Journal
Subjects:
Online Access:https://romj.org/node/575
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850132043002806272
author Alireza Sadeghi
Fazlollah Ayatollahi
Sana Gheytarani
Somayeh Abdollahi Sabet
Mina Rostami
author_facet Alireza Sadeghi
Fazlollah Ayatollahi
Sana Gheytarani
Somayeh Abdollahi Sabet
Mina Rostami
author_sort Alireza Sadeghi
collection DOAJ
description Introduction — Patients with rheumatic diseases (RD) may be at an increased risk of developing severe symptoms of COVID-19. They are likely to have a wide range of manifestations and outcomes that can make it difficult to control the disease. The goal of this study was to investigate the clinical manifestations, severity, and outcomes of adult patients with RD hospitalized for COVID-19. Methods — We conducted a retrospective cross-sectional study. Eligible rheumatology patients were confirmed by a rheumatologist in compliance with American College of Rheumatology (ACR) criteria and had COVID-19 confirmed by computed tomography (CT) scan or polymerase chain reaction (PCR) test. Information about their gender, age, and clinical manifestations of COVID-19, along with the variables pertaining to the outcomes of the patients, was collected. Descriptive statistics and Fisher’s exact test were performed using IBM SPSS Statistics software. Results — A total of 105 patients with RD and COVID-19 were included. Rheumatoid arthritis (RA) was the most common disease (86 patients). Most patients were female (75.2%). The mean age of the participants was 58.97±12.25 years. Myalgia/arthralgia was the predominant symptom of COVID-19 (77.1%), followed by shortness of breath, cough, and fever. Only platelet count exhibited a significant association with the type of RD (p = 0.004). Conclusion — Common adverse outcomes included moderate severity based on CT grading, anemia, oxygen saturation levels (SpO2) below 90%, and severe CT-based grade of severity. The mortality rate was relatively high.
format Article
id doaj-art-8d22ec5ef4e84296be888391979582c1
institution OA Journals
issn 2304-3415
language English
publishDate 2024-09-01
publisher Limited liability company «Science and Innovations» (Saratov)
record_format Article
series Russian Open Medical Journal
spelling doaj-art-8d22ec5ef4e84296be888391979582c12025-08-20T02:32:19ZengLimited liability company «Science and Innovations» (Saratov)Russian Open Medical Journal2304-34152024-09-01133e030210.15275/rusomj.2024.0302Investigating the clinical manifestations, severity and outcomes of COVID-19 among inpatients with rheumatic diseases: A retrospective cross-sectional study in IranAlireza SadeghiFazlollah AyatollahiSana GheytaraniSomayeh Abdollahi SabetMina RostamiIntroduction — Patients with rheumatic diseases (RD) may be at an increased risk of developing severe symptoms of COVID-19. They are likely to have a wide range of manifestations and outcomes that can make it difficult to control the disease. The goal of this study was to investigate the clinical manifestations, severity, and outcomes of adult patients with RD hospitalized for COVID-19. Methods — We conducted a retrospective cross-sectional study. Eligible rheumatology patients were confirmed by a rheumatologist in compliance with American College of Rheumatology (ACR) criteria and had COVID-19 confirmed by computed tomography (CT) scan or polymerase chain reaction (PCR) test. Information about their gender, age, and clinical manifestations of COVID-19, along with the variables pertaining to the outcomes of the patients, was collected. Descriptive statistics and Fisher’s exact test were performed using IBM SPSS Statistics software. Results — A total of 105 patients with RD and COVID-19 were included. Rheumatoid arthritis (RA) was the most common disease (86 patients). Most patients were female (75.2%). The mean age of the participants was 58.97±12.25 years. Myalgia/arthralgia was the predominant symptom of COVID-19 (77.1%), followed by shortness of breath, cough, and fever. Only platelet count exhibited a significant association with the type of RD (p = 0.004). Conclusion — Common adverse outcomes included moderate severity based on CT grading, anemia, oxygen saturation levels (SpO2) below 90%, and severe CT-based grade of severity. The mortality rate was relatively high.https://romj.org/node/575covid-19inpatientsrheumatic diseasesoutcomes
spellingShingle Alireza Sadeghi
Fazlollah Ayatollahi
Sana Gheytarani
Somayeh Abdollahi Sabet
Mina Rostami
Investigating the clinical manifestations, severity and outcomes of COVID-19 among inpatients with rheumatic diseases: A retrospective cross-sectional study in Iran
Russian Open Medical Journal
covid-19
inpatients
rheumatic diseases
outcomes
title Investigating the clinical manifestations, severity and outcomes of COVID-19 among inpatients with rheumatic diseases: A retrospective cross-sectional study in Iran
title_full Investigating the clinical manifestations, severity and outcomes of COVID-19 among inpatients with rheumatic diseases: A retrospective cross-sectional study in Iran
title_fullStr Investigating the clinical manifestations, severity and outcomes of COVID-19 among inpatients with rheumatic diseases: A retrospective cross-sectional study in Iran
title_full_unstemmed Investigating the clinical manifestations, severity and outcomes of COVID-19 among inpatients with rheumatic diseases: A retrospective cross-sectional study in Iran
title_short Investigating the clinical manifestations, severity and outcomes of COVID-19 among inpatients with rheumatic diseases: A retrospective cross-sectional study in Iran
title_sort investigating the clinical manifestations severity and outcomes of covid 19 among inpatients with rheumatic diseases a retrospective cross sectional study in iran
topic covid-19
inpatients
rheumatic diseases
outcomes
url https://romj.org/node/575
work_keys_str_mv AT alirezasadeghi investigatingtheclinicalmanifestationsseverityandoutcomesofcovid19amonginpatientswithrheumaticdiseasesaretrospectivecrosssectionalstudyiniran
AT fazlollahayatollahi investigatingtheclinicalmanifestationsseverityandoutcomesofcovid19amonginpatientswithrheumaticdiseasesaretrospectivecrosssectionalstudyiniran
AT sanagheytarani investigatingtheclinicalmanifestationsseverityandoutcomesofcovid19amonginpatientswithrheumaticdiseasesaretrospectivecrosssectionalstudyiniran
AT somayehabdollahisabet investigatingtheclinicalmanifestationsseverityandoutcomesofcovid19amonginpatientswithrheumaticdiseasesaretrospectivecrosssectionalstudyiniran
AT minarostami investigatingtheclinicalmanifestationsseverityandoutcomesofcovid19amonginpatientswithrheumaticdiseasesaretrospectivecrosssectionalstudyiniran